PEPG
PEPG
NASDAQ · Biotechnology

Pepgen Inc

$1.85
+0.06 (+3.35%)
As of May 9, 1:55 AM ET ·
Financial Highlights (FY 2025)
Revenue
77.00M
Net Income
-1,399,615
Gross Margin
54.2%
Profit Margin
-1.8%
Rev Growth
+16.0%
D/E Ratio
0.13
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 54.2% 54.2% 54.2%
Operating Margin -1.6% -1.8% -1.5%
Profit Margin -1.8% -1.8% -2.2%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 77.00M 76.19M 65.35M
Gross Profit 41.73M 41.29M 35.42M
Operating Income -1,205,223 -1,349,590 -1,002,959
Net Income -1,399,615 -1,371,226 -1,459,846
Gross Margin 54.2% 54.2% 54.2%
Operating Margin -1.6% -1.8% -1.5%
Profit Margin -1.8% -1.8% -2.2%
Rev Growth +16.0% +7.1% -1.4%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 31.45M 30.29M 37.21M
Total Equity 233.19M 257.46M 235.98M
D/E Ratio 0.13 0.12 0.16
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -1,495,155 -1,465,448 -1,363,438
Free Cash Flow -1,111,108 -1,336,142 -1,081,347